Ocuphire Pharma (Nasdaq: OCUP) has announced the acquisition of Opus Genetics, a clinical-stage gene therapy company focused ...

Ipsen has reported strong Q3 2024 results, with sales reaching 837 million euros ($884 million), an 8.6% year-on-year ...

Connecticut, USA-based Modifi Biosciences today announced that the company has been acquired by pharma giant Merck & Co (NYSE ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab ...

US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was ...

Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...

Shares in Sangamo Therapeutics (Nasdaq: SGMO) surged around 40% on Tuesday, following the announcement that the US Food and ...

The US Food and Drug Administration (FDA) yesterday approved Abrysvo (respiratory syncytial virus vaccine). Developed and ...

The US Department of Health and Human Services (HHS), through the Office of Assistant Secretary for Planning and Evaluation ...

GLP-1 therapies are expanding beyond obesity treatment, with research exploring their potential for conditions like liver ...

Shares of Swedish drugmaker Camurus fell almost 10% to 588.50 kroner yesterday after it revealed that the US Food and Drug ...

South Korean firm SK bioscience announced that Indonesia’s Food and Drug Agency, BPOM (Badan Pengawas Obat dan Makanan), has ...